This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Xolair
  • /
  • Mode of Action Study of Omalizumab in Patients Wit...
Clinical trial

Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment

Read time: 1 mins
Last updated:1st Apr 2012
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest